Skip to main content
Equibles
GPLL logo

GPLL · GPL Holdings, Inc.

Track GPLL — free

Use GPLL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GPLL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 At close · Sep 17
Rebalance outlook locked
Going-concern doubt — flagged Apr 26, 2024

Substantial doubt about the company's ability to continue as a going concern.

“The Company demonstrates adverse conditions that raise substantial doubt about the Company's ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, no revenue, operating loss, working capital deficiency, and other adverse key financial ratios.”
View the 10-Q filed Apr 26, 2024
Market Cap
$1.99M
Shares
176.29M
Volume · Sep 17 1500 Avg daily vol (7 sessions) 4536

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.01 52W close$0.01–0.09 Avg vol 30d6K Short int144 · 0.0% of shares · 1.0d Short vol100% DataOct 2022–Sep 2026 Filing10-Q · Apr 26

Latest documents

2024
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$55,584
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$9,133
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+28.7%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −57%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −79%
trailing
6-month return −92%
trailing
YTD return −66%
this year
Relative strength −111%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 11300%
annualized · 1-yr
Max drawdown −100%
past year
ATR 59.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−57% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 1% Range high $0
vs 50-day avg -57%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GPLL
GPL Holdings, Inc.
this stock
$1.99M -66.2% — — 0.0%
VRTX
Vertex Pharmaceuticals Inc
 $137.57B +19.7% +46.2% 34.9 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $98.40B +23.2% +20.8% 21.0 2.1%
MRNA
Moderna, Inc.
 $93.61B +684.5% +4.3% — 8.2%
CSLLY
Csl Ltd
 $66.55B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
144
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
100%
As of
Oct 8, 2026
Short Total
View
Fails to Deliver
FTD shares
2.0K
Value
$100
As of
Dec 29, 2025
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-62.7K
View
Filings
SEC Filings
Latest
NT 10-Q
Filed
Jun 17, 2024
This year
0
View

Performance

5D 20D 120D MTD YTD
GPLL -38.9% -78.9% -92.5% -38.6% -66.2%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY -39.6% -78.0% -110.7% -38.0% -78.0%
Key facts CIK 1883083